Business Description
ShockWave Medical Inc
NAICS : 339112
SIC : 3841
Description
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.76 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 0.75 | |||||
| Interest Coverage | 57.87 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 54.92 | |||||
| Beneish M-Score | -1.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 145.6 | |||||
| 3-Year EBITDA Growth Rate | 65.1 | |||||
| 3-Year EPS without NRI Growth Rate | 50.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.54 | |||||
| 9-Day RSI | 51.96 | |||||
| 14-Day RSI | 51.46 | |||||
| 6-1 Month Momentum % | 40.39 | |||||
| 12-1 Month Momentum % | 46.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.32 | |||||
| Quick Ratio | 4.41 | |||||
| Cash Ratio | 3.4 | |||||
| Days Inventory | 317.15 | |||||
| Days Sales Outstanding | 40.14 | |||||
| Days Payable | 32.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.36 | |||||
| Operating Margin % | 16.98 | |||||
| Net Margin % | 15.11 | |||||
| ROE % | 22.11 | |||||
| ROA % | 16.07 | |||||
| ROIC % | 48.21 | |||||
| ROC (Joel Greenblatt) % | 59.49 | |||||
| ROCE % | 19.51 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 191.08 | |||||
| Forward PE Ratio | 87.23 | |||||
| PE Ratio without NRI | 191.08 | |||||
| PS Ratio | 28.44 | |||||
| PB Ratio | 32.82 | |||||
| Price-to-Tangible-Book | 32.82 | |||||
| Price-to-Free-Cash-Flow | 212.14 | |||||
| Price-to-Operating-Cash-Flow | 168.66 | |||||
| EV-to-EBIT | 172.05 | |||||
| EV-to-EBITDA | 155.73 | |||||
| EV-to-Revenue | 27.05 | |||||
| EV-to-Forward-Revenue | 15.8 | |||||
| EV-to-FCF | 202.78 | |||||
| Price-to-Graham-Number | 16.69 | |||||
| Price-to-Net-Current-Asset-Value | 41.76 | |||||
| Price-to-Net-Cash | 88.84 | |||||
| Earnings Yield (Greenblatt) % | 0.57 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SWAV
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 363.715 | ||
| EPS (TTM) ($) | 1.46 | ||
| Beta | 1.38 | ||
| Volatility % | 66.63 | ||
| 14-Day RSI | 51.46 | ||
| 14-Day ATR ($) | 14.170545 | ||
| 20-Day SMA ($) | 279.6365 | ||
| 12-1 Month Momentum % | 46.41 | ||
| 52-Week Range ($) | 113.36 - 314.9 | ||
| Shares Outstanding (Mil) | 35.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ShockWave Medical Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
ShockWave Medical Inc Analysis
Share your researchHeadlines
See More
No news.